RECENT CLINICAL GUIDELINES FOR TREATING HYPERTENSION – NEED AND VALUE OF TITRATING ANTI-HYPERTENSIVE MEDICATIONS Suzanne Oparil, MD Distinguished Professor of Medicine, Professor of Cell, Developmental and Integrative - Integrative medicine - Document - PDFSEARCH.IO

First Page	Meta Content
	RECENT CLINICAL GUIDELINES FOR TREATING HYPERTENSION – NEED AND VALUE OF TITRATING ANTI-HYPERTENSIVE MEDICATIONS Suzanne Oparil, MD Distinguished Professor of Medicine, Professor of Cell, Developmental and Integrative Add to Reading List Open Document File Size: 1,78 MB Share Result on Facebook City Birmingham / Recommendation Evidence / / Company Amarin Pharma Inc. / Forest Labs Inc. / AstraZeneca AB / Medtronic Vascular Inc. / Arbor Pharmaceuticals LLC / BP / Novartis / Takeda Global R&D / Bayer Healthcare Pharma Inc. / Merck and Co. / Daiichi Sankyo Inc. / / Facility University of Alabama / / MedicalCondition FOR TREATING HYPERTENSION / High Blood Pressure / cardiovascular disease / / Organization American Heart Association / National Institute of Health / Food and Drug Administration / University of Alabama at Birmingham / Duke Univ / American Society of Hypertension / / Person Vascular Biology / Trials Testing / Silver Spring / Suzanne Oparil / Disclosure Suzanne Oparil / / Position Professor of Medicine / Professor of Cell / Consultant / President / Director / Cardiovascular Disease Co-chair / Co-chair / / ProvinceOrState Alabama / / Technology CVD / / URL http / SocialTag Antihypertensive drug Daiichi Sankyo Blood pressure Stroke Evidence-based medicine Cardiovascular disease Health Hypertension Medicine

RECENT CLINICAL GUIDELINES FOR TREATING HYPERTENSION – NEED AND VALUE OF TITRATING ANTI-HYPERTENSIVE MEDICATIONS Suzanne Oparil, MD Distinguished Professor of Medicine, Professor of Cell, Developmental and Integrative Add to Reading List